Father Kevin FitzGerald, Professor of Medical Humanities, Creighton University | Onyx Live | Cell & Gene Meeting on the Med 2026

Cell and gene therapy promises to cure thousands of inherited and acquired diseases, yet the speed of the science is outrunning the ethical frameworks meant to govern it.

A bioethicist with a PhD in molecular genetics and a seat on the Vatican's Pontifical Academy for Life sits in a rare position to bridge the two.

Father Kevin FitzGerald, S.J., is a Jesuit priest, the John A. Creighton University Professor, and Chair of Medical Humanities at Creighton University, and a longstanding adviser to the Vatican, Catholic health systems and bishops' conferences on the ethics of human genetic engineering, stem-cell research and personalised medicine. With dual Georgetown PhDs in molecular genetics and bioethics, his work spans abnormal gene expression in cancer and the ethical questions raised as CRISPR, germline editing and one-shot gene therapies move from the lab into routine clinical practice.

At Meeting on the Med 2026, reporting for Onyx, Federico Citterich sat down with Father Kevin FitzGerald to find out more.

A special thanks to our Onyx Live sponsors:

Cellares - delivering cell therapy manufacturing excellence at scale across a global network of IDMO smart factories https://www.cellares.com/